CN113876656A - Black eye and pouch removing soluble beautifying microneedle patch composition and preparation method thereof - Google Patents
Black eye and pouch removing soluble beautifying microneedle patch composition and preparation method thereof Download PDFInfo
- Publication number
- CN113876656A CN113876656A CN202111271937.9A CN202111271937A CN113876656A CN 113876656 A CN113876656 A CN 113876656A CN 202111271937 A CN202111271937 A CN 202111271937A CN 113876656 A CN113876656 A CN 113876656A
- Authority
- CN
- China
- Prior art keywords
- eye
- extract
- composition
- microneedle patch
- molecular weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 74
- 208000035753 Periorbital contusion Diseases 0.000 title claims abstract description 40
- 235000002673 Dioscorea communis Nutrition 0.000 title claims abstract description 34
- 241000544230 Dioscorea communis Species 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 31
- 239000002537 cosmetic Substances 0.000 claims abstract description 48
- 239000000017 hydrogel Substances 0.000 claims abstract description 35
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims abstract description 28
- 241000157280 Aesculus hippocastanum Species 0.000 claims abstract description 17
- 235000010181 horse chestnut Nutrition 0.000 claims abstract description 17
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229960001948 caffeine Drugs 0.000 claims abstract description 14
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229940059958 centella asiatica extract Drugs 0.000 claims abstract description 14
- 229920000669 heparin Polymers 0.000 claims abstract description 13
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 claims abstract description 13
- 229960001008 heparin sodium Drugs 0.000 claims abstract description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 36
- 238000003756 stirring Methods 0.000 claims description 31
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 24
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 24
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 24
- 239000002313 adhesive film Substances 0.000 claims description 19
- 239000007788 liquid Substances 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 235000011187 glycerol Nutrition 0.000 claims description 13
- 239000004745 nonwoven fabric Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 7
- 230000001681 protective effect Effects 0.000 claims description 7
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 5
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 5
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 5
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 5
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims description 5
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims description 5
- 235000002906 tartaric acid Nutrition 0.000 claims description 5
- 239000011975 tartaric acid Substances 0.000 claims description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 3
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 3
- 244000042664 Matricaria chamomilla Species 0.000 claims description 3
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 3
- 240000001341 Reynoutria japonica Species 0.000 claims description 3
- 235000018167 Reynoutria japonica Nutrition 0.000 claims description 3
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 3
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 3
- BWZOPYPOZJBVLQ-UHFFFAOYSA-K aluminium glycinate Chemical compound O[Al+]O.NCC([O-])=O BWZOPYPOZJBVLQ-UHFFFAOYSA-K 0.000 claims description 3
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims description 3
- 229920002674 hyaluronan Polymers 0.000 claims description 3
- 229960003160 hyaluronic acid Drugs 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000001331 rosmarinus officinalis leaf Substances 0.000 claims description 3
- 229940092665 tea leaf extract Drugs 0.000 claims description 3
- GULNRVTWPJODDE-UHFFFAOYSA-K aluminum;2-(dihydroxyamino)acetate Chemical compound [Al+3].ON(O)CC([O-])=O.ON(O)CC([O-])=O.ON(O)CC([O-])=O GULNRVTWPJODDE-UHFFFAOYSA-K 0.000 claims description 2
- 239000000835 fiber Substances 0.000 claims description 2
- 239000002985 plastic film Substances 0.000 claims description 2
- 229920006255 plastic film Polymers 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 210000001508 eye Anatomy 0.000 abstract description 40
- 230000000694 effects Effects 0.000 abstract description 33
- 230000035515 penetration Effects 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 6
- 230000006870 function Effects 0.000 abstract description 6
- 230000004089 microcirculation Effects 0.000 abstract description 6
- 208000003464 asthenopia Diseases 0.000 abstract description 5
- 230000007794 irritation Effects 0.000 abstract description 5
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 230000002500 effect on skin Effects 0.000 abstract description 4
- 230000000474 nursing effect Effects 0.000 abstract description 4
- 238000005562 fading Methods 0.000 abstract description 3
- 238000012360 testing method Methods 0.000 description 15
- 239000010410 layer Substances 0.000 description 10
- 244000146462 Centella asiatica Species 0.000 description 7
- 235000004032 Centella asiatica Nutrition 0.000 description 7
- 210000000744 eyelid Anatomy 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- YFESOSRPNPYODN-RSMWSHJLSA-N (2s,3s,4s,5r,6r)-6-[[(4s,6ar,6bs,8r,8ar,9r,10r,14br)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(z)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3,5-bis[[(2s,3r,4s, Chemical group O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)OC1CC[C@]2(C)C3CC=C4[C@@]([C@@]3(CCC2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(CC14)(C)C)OC(=O)C(\C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O.O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)OC1CC[C@]2(C)C3CC=C4[C@@]([C@@]3(CCC2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(CC14)(C)C)OC(=O)C(/C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YFESOSRPNPYODN-RSMWSHJLSA-N 0.000 description 2
- AXNVHPCVMSNXNP-GKTCLTPXSA-N Aescin Natural products O=C(O[C@H]1[C@@H](OC(=O)C)[C@]2(CO)[C@@H](O)C[C@@]3(C)[C@@]4(C)[C@@H]([C@]5(C)[C@H]([C@](CO)(C)[C@@H](O[C@@H]6[C@@H](O[C@H]7[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)[C@@H](O)[C@H](O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O7)[C@@H](C(=O)O)O6)CC5)CC4)CC=C3[C@@H]2CC1(C)C)/C(=C/C)/C AXNVHPCVMSNXNP-GKTCLTPXSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- -1 triterpenoid saponin compound Chemical class 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- PFWLFWPASULGAN-UHFFFAOYSA-N 7-methylxanthine Chemical compound N1C(=O)NC(=O)C2=C1N=CN2C PFWLFWPASULGAN-UHFFFAOYSA-N 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010052139 Eye oedema Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 244000258271 Galium odoratum Species 0.000 description 1
- 235000008526 Galium odoratum Nutrition 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010021034 Hypometabolism Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 208000025174 PANDAS Diseases 0.000 description 1
- 208000021155 Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection Diseases 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000083513 Punctum Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 description 1
- 229940011658 asiatic acid Drugs 0.000 description 1
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 description 1
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 1
- 229940022757 asiaticoside Drugs 0.000 description 1
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003054 facial bone Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- PRAUVHZJPXOEIF-AOLYGAPISA-N madecassic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2[C@H](O)C[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C PRAUVHZJPXOEIF-AOLYGAPISA-N 0.000 description 1
- 229940011656 madecassic acid Drugs 0.000 description 1
- BUWCHLVSSFQLPN-UHFFFAOYSA-N madecassic acid Natural products CC1CCC2(CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(C5CCC34C)C(=O)O)C2C1C)C(=O)OC6OC(COC7OC(CO)C(OC8OC(C)C(O)C(O)C8O)C(O)C7O)C(O)C(O)C6O BUWCHLVSSFQLPN-UHFFFAOYSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000004855 vascular circulation Effects 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0204—Specific forms not provided for by any of groups A61K8/0208 - A61K8/14
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0046—Solid microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0053—Methods for producing microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0061—Methods for using microneedles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Anesthesiology (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a cosmetic microneedle patch composition capable of removing black eye circles and eye bags and a preparation method thereof. The micro-needle film-sticking composition comprises a base, a needle body positioned on the base, and a hydrogel film with the functions of relieving and fixing the needle body, wherein the needle body is internally embedded with a composition for removing black eye circles and under-eye bags: 0.1-5% of centella asiatica extract, 0.1-5% of aesculus hippocastanum extract, 0.1-2% of heparin sodium and 0.1-3% of caffeine. The invention is specially designed for weak skin around eyes, not only promotes skin microcirculation around eyes, improves red blood streak, reduces capillary vessel penetration, but also can enhance the activity of skin basal layer cells. The composition with the black eye and pouch removing effects is wrapped by the soluble cosmetic microneedle, so that the composition can be better absorbed through skin penetration to play a better nursing effect, is beneficial to more slow release of the effect composition, has small irritation, has excellent effect on skin around eyes and is easy to use. The microneedle patch prepared by the invention has the effects of relieving eye fatigue, removing dark circles, fading pouches and tightening skin around eyes.
Description
Technical Field
The invention relates to a skin care product and a preparation method thereof, belongs to the technical field of daily chemicals, and particularly relates to a soluble cosmetic microneedle patch composition for removing dark circles and under-eye puffiness and a preparation method thereof.
Background
With the development of science and technology, the excessive use of social electronic products brings burden to eyes, and simultaneously causes various eye problems, such as black eye circles and under-eye puffiness. The black eye, commonly called "panda eye", is divided into two categories: one is a cyan black eye ring, which is mainly caused by staying up all night, unstable emotion, eye fatigue, aging, insufficient oxygen supply of red blood cells of eye skin, excessive accumulation of carbon dioxide and metabolic wastes in venous blood vessels, chronic hypoxia, dark blood and venous blood retention in venous blood vessels or micro blood vessels. The other is dark brown eye, which is mainly due to pigmentation of the eye caused by melanin production or hypometabolism.
The older the person, the thinner the subcutaneous fat around the eye becomes, so the more visible the dark circles. The pouch refers to the swollen and swollen tissue of the lower eyelid and hangs in the shape of a bag. The clinical manifestations are that the skin of the lower eyelid is loose and accumulated, the intraorbital fat is prolapsed and hung in a bag shape, the outer canthus position moves downwards, the lower eyelid margin is not tightly attached to the eyeball, the radian of the lower eyelid margin is increased, the lower lacrimal punctum moves outwards to overflow tears, and the secondary relaxation of the lower eyelid support structure is caused by the aging absorption of facial bones. The formation of the pouch is due to the fact that, in addition to genetic factors, the metabolism function of a human body is weakened and microcirculation is not smooth due to various factors, and the skin around the eyes is thin and is only a quarter of the thickness of the skin of the face, so that fat is easily accumulated in the area to form the pouch.
The irregular diet and sub-healthy lifestyle of modern people have led to a rapid growth and an increasing youthful growth of the population with long dark circles and bags. The pouch not only affects the appearance, but also the health of the eye.
In the prior art, the pouch can be removed through an operation, but the operation method has the disadvantages of high potential risk, high price, long post-operation recovery period and possible side effect; in addition, the eye skin problem can be improved by applying eye cream, but the common eye cream has slow effect and has no obvious effect on dark circles and under-eye puffiness.
Disclosure of Invention
In order to overcome the problems in the prior art, the invention aims to provide a soluble cosmetic microneedle patch composition for removing black eye circles and under-eye pouches.
The invention also aims to provide a preparation method of the soluble cosmetic microneedle patch composition for removing the black eye circles and the pouches, which is simple, low in energy consumption and production cost and easy to realize continuous mass production.
The invention is realized by adopting the following technical scheme.
A cosmetic microneedle patch composition for removing dark circles and pouches comprises a base, a needle body on the base, and a hydrogel patch for relieving and fixing the needle body; the needle body is internally embedded with a composition for removing black eye circles and under-eye bags, and the composition for removing black eye circles and under-eye bags comprises the following components in percentage by total weight of the micro-needles:
0.1-5% of centella asiatica extract, 0.1-5% of aesculus hippocastanum extract, 0.1-2% of heparin sodium and 0.1-3% of caffeine.
Preferably, the black eye removing and pouch removing composition comprises the following components in percentage by weight based on the total weight of the microneedle:
0.2-2% of centella asiatica extract, 0.2-2% of aesculus hippocastanum extract, 0.1-0.5% of heparin sodium and 0.1-1% of caffeine.
Preferably, the preparation of the composition for removing dark circles and under-eye bags further comprises the following components in percentage by weight:
5-15% of glycerin, 1-3% of low molecular weight sodium hyaluronate and 6-10% of high molecular weight sodium hyaluronate.
Preferably, the soluble cosmetic microneedle is conical, the main component is hyaluronic acid, the length of the needle head is 150-.
Preferably, the hydrogel adhesive film has 4 layers, and the components are 15-25. The hydrogel adhesive film consists of non-woven fabric, hydrogel, active component layer and protecting film.
The non-woven fabric is non-woven fabric and is formed by solidifying high polymer slices, short fibers or filaments.
The hydrogel comprises the following specific components in percentage by weight of the hydrogel adhesive film: 5-15% of glycerin, 1-2% of sodium polyacrylate, 1-3% of aluminum dihydroxyglycinate, 0.5-2% of cellulose gum, 1-5% of tartaric acid, 5-15% of butanediol and 50-80% of water.
According to the total weight of the hydrogel adhesive film, the active component layer comprises the following specific components:
0.1-2% of centella asiatica extract, 0.2-3% of polygonum cuspidatum root extract, 0.2-3% of scutellaria baicalensis root extract, 0.1-2% of tea leaf extract, 0.2-3% of glycyrrhiza glabra root extract, 0.3-1% of chamomile flower extract and 0.1-2% of rosemary leaf extract.
The protective film is a white plastic film.
In another aspect, the present invention provides a method for preparing a black eye-removing pouch-soluble cosmetic microneedle patch composition, the method comprising the steps of:
1) preparation of viscous liquid:
adding the composition for removing dark circles and pouches into the balance of water, stirring and dissolving, adding 5-15% of glycerol, 1-3% of sodium hyaluronate (low molecular weight) and 6-10% of sodium hyaluronate (high molecular weight), continuously stirring to enable the mixture to be uniformly swelled, and centrifuging to remove bubbles to obtain the viscous liquid.
2) Preparation of soluble cosmetic microneedles:
and injecting the viscous liquid into a microneedle mould, drying and demoulding to obtain the soluble cosmetic microneedle.
3) Preparation of hydrogel adhesive film:
uniformly mixing 1-2% of sodium polyacrylate and 1-3% of dihydroxy aluminum glycinate, adding 5-15% of glycerol and 5-15% of butanediol, and fully stirring to obtain a phase A solution;
adding 0.5-2% cellulose gum into water, stirring, adding 1-5% tartaric acid, adding active component layer, stirring to dissolve completely to obtain B phase solution;
and adding the B phase solution into the A phase solution, stirring in vacuum to obtain hydrogel paste, and finally coating the hydrogel paste on a coating machine together with a non-woven fabric and a protective film to obtain the hydrogel adhesive film.
Preferably, in the step 1), the molecular weight of the low molecular weight sodium hyaluronate is 2000-10000 daltons; the molecular weight of the high molecular weight sodium hyaluronate is 40-100 ten thousand daltons.
The mass ratio of the high molecular weight sodium hyaluronate to the low molecular weight sodium hyaluronate is 1: 3.5-5.5.
Preferably, in step 2), the microneedle mould is arc-shaped, and two ends of the microneedle mould are arc-shaped.
Preferably, in the step 2), the drying temperature is room temperature, the humidity is 15-25%, and the drying time is 12-24 h.
Preferably, in the step 3), the stirring speed of the vacuum stirring is 50-120r/min, and the stirring time is 5-15 min.
By means of the technical scheme, the invention has the following beneficial technical effects:
1) the invention is specially designed for weak skin around eyes, not only promotes skin microcirculation around eyes, improves red blood streak, reduces capillary vessel penetration, but also can enhance the activity of skin basal layer cells.
2) The composition with the black eye and pouch removing effects is wrapped by the soluble cosmetic microneedle, so that the composition can be better absorbed through skin penetration to play a better nursing effect, is beneficial to more slow release of the effect composition, has small irritation, has excellent effect on skin around eyes and is easy to use.
3) The microneedle patch prepared by the invention has the effects of relieving eye fatigue, removing dark circles, fading pouches and tightening skin around eyes.
Drawings
Fig. 1 is a structural diagram of a soluble cosmetic microneedle for removing dark circles and bags under the eyes provided by the invention.
Fig. 2 is a mechanism diagram of the inventive soluble cosmetic microneedle for removing dark eye circles and under-eye bags on skin.
Detailed Description
The technical solution of the present invention is further specifically described below by way of specific examples. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
As shown in figure 1, the invention discloses a cosmetic microneedle patch composition capable of removing dark circles and bags under the eyes and a preparation method thereof. The micro-needle film sticking composition comprises a base, a needle body positioned on the base and a hydrogel film which is used for relieving and fixing the needle body, wherein the base is composed of hyaluronic acid. The needle body is internally embedded with a composition for removing black eye and eye bags, and the composition comprises:
0.1-5% of centella asiatica extract, 0.1-5% of aesculus hippocastanum extract, 0.1-2% of heparin sodium and 0.1-3% of caffeine.
The hydrogel adhesive film consists of non-woven fabric, hydrogel, active component layer and protecting film. The non-woven fabric has the functions of improving the air permeability of the film, the hydrogel body has the function of locking water for a long time, the active component layer has the functions of slowly releasing water, assisting in moisture preservation and relieving irritation and sensitivity, and the protective film has the function of preventing nutrition and water loss of the gel.
As shown in figure 2, the micro-needle can penetrate the surface layer of the skin and directly act on the deep layer of the skin to release the active components of the composition for removing the dark circles and the bags under the eyes, so that the composition can be better absorbed.
The following description focuses on the efficacy of the raw materials of the composition.
Centella asiatica extract
The effective components of the centella asiatica comprise total asiaticoside, asiatic acid, madecassic acid and the like, and researches show that the centella asiatica has an antioxidation effect, can dispel aged cuticles, promote protein regeneration, increase skin elasticity, enable skin to be compact and smooth, and also has the effects of clearing heat and removing toxicity, and promoting diuresis and relieving swelling. Centella asiatica contains a plurality of a-coumarol-type triterpene components, has tranquilizing and stabilizing effects, and can help to calm skin and relieve sensitivity when added into skin care products.
② an extract of Aesculus hippocastanum
The main component of the European aesculus hippocastanum extract is aescin which is a triterpenoid saponin compound, and the aescin is hemolytic saponin, has the effects of resisting edema, resisting exudation, restoring capillary permeability, improving blood circulation and the like, and can obviously improve the symptoms of eye edema caused by poor microcirculation.
③ heparin sodium
The heparin sodium is an acidic mucopolysaccharide substance, and researches show that the heparin sodium can increase the vascular permeability of the skin, improve the local vascular circulation, promote the supply of skin nutrition and the excretion of metabolic waste, and has good health care and maintenance functions on the skin.
Fourthly, caffeine
Caffeine is an alkaloid of the methylxanthine family, and is chemically very similar to some plants, such as tea, mate and melon. In addition to the cardiovascular and nervous systems that can be affected by caffeine, the skin can also be affected in the human body. It has been found that caffeine has antioxidant and skin-tranquilizing effects, and can be added into eye cream to promote blood circulation of skin tissue and relieve edema of tired eyes.
Therefore, the composition formed by combining the four components not only promotes the skin microcirculation around the eyes, improves the red blood filaments, reduces the capillary vessel penetration, but also can enhance the activity of skin basal layer cells.
According to the invention, the composition with the black eye and pouch removing effects is wrapped by the soluble cosmetic microneedle, so that the composition can be better absorbed through skin penetration to play a better nursing effect, and the composition is more slowly released, has small irritation, has excellent effect on skin around eyes and is easy to use. The microneedle action mechanism is that after the microneedle is attached to the skin, the soluble microneedle is injected into the skin, the active ingredients are released along with the melting of the crystal, the melting of the crystal is slow, and the crystal is completely melted and slowly released within about two hours.
The following percentage contents are all weight percentage contents. All the raw material components of the invention are commercial products. Centella asiatica extract was obtained from East BeautyCo.Ltd, Aesculus hippocastanum extract was obtained from Pasf, heparin sodium was obtained from Huaxi organism, and caffeine was obtained from lipoid Kosmetic.
The preparation method of herba Centellae extractive solution comprises pulverizing fresh herba Centellae to obtain herba Centellae powder; placing the powder in a ball mill, starting the ball mill to perform ultramicro wall-breaking grinding and simultaneously performing ozone sterilization to obtain the wall-breaking micro powder of centella asiatica; extracting, carrying out solid-liquid separation, and taking liquid to obtain a wall-broken solution of the centella asiatica; and finally, performing membrane separation and concentration on the asiatic pennywort herb wall-broken liquid to obtain the asiatic pennywort herb extracting solution.
The Aesculus hippocastanum extract is prepared by washing seeds of Aesculus hippocastanum with a weight ratio of 50-55: adding deionized water according to the mass ratio of 35-50, and coarsely crushing to obtain mixed crude pulp of aesculus hippocastanum seeds; and stirring, centrifuging and filtering the obtained aesculus hippocastanum seed fermentation product, and removing filter residues to obtain the aesculus hippocastanum extract.
Centella asiatica extract, polygonum cuspidatum root extract, scutellaria baicalensis root extract, tea leaf extract, glycyrrhiza glabra root extract, chamomile flower extract, and rosemary leaf extract were obtained from Beijing university of Industrial and commercial sciences or Galium odoratum leaf Biotech Co.
Example 1
A preparation method of a soluble cosmetic microneedle patch composition for removing dark circles and pouches comprises the following steps:
1) preparation of viscous liquid:
adding 1% of centella asiatica extract, 1.2% of aesculus hippocastanum extract, 0.5% of heparin sodium and 0.8% of caffeine into the balance of water, stirring and dissolving, adding 10% of glycerol, 2% of sodium hyaluronate (molecular weight of 5000 daltons) and 8% of sodium hyaluronate (molecular weight of 60 ten thousand daltons), continuously stirring to enable the mixture to be uniformly swelled, and centrifuging to remove bubbles to obtain the viscous liquid.
2) Preparation of soluble cosmetic microneedles:
and injecting the viscous liquid into an arc microneedle mould, drying for 20 hours at room temperature and under the condition that the humidity is 20%, and demoulding to obtain the soluble cosmetic microneedle.
3) Preparation of hydrogel adhesive film:
uniformly mixing 1.5% of sodium polyacrylate and 2% of dihydroxy aluminum glycinate, adding 10% of glycerol and 10% of butanediol, and fully stirring to obtain a phase A solution;
adding 1% cellulose gum into water, stirring, adding 3% tartaric acid, adding 0.8% herba Centellae extract, 0.6% rhizoma Polygoni Cuspidati extract, 0.5% radix Scutellariae extract, 0.6% folium Camelliae sinensis extract, 0.8% radix Glycytthizae extract, 0.7% flos Matricariae Chamomillae extract and 0.5% herba Rosmarini officinalis leaf extract, stirring to dissolve completely to obtain phase B solution;
and adding the B phase solution into the A phase solution, stirring in vacuum to obtain hydrogel paste, stirring at 80r/min for 10min, and finally coating on a coating machine together with a non-woven fabric and a protective film to obtain the hydrogel adhesive film.
Example 2
A preparation method of a soluble cosmetic microneedle patch composition for removing dark circles and pouches comprises the following steps:
adding 0.6% of centella asiatica extract, 0.8% of aesculus hippocastanum extract, 0.3% of heparin sodium and 0.5% of caffeine into the balance of water, stirring and dissolving, adding 10% of glycerol, 2% of sodium hyaluronate (with the molecular weight of 5000 daltons) and 8% of sodium hyaluronate (with the molecular weight of 60 ten thousand daltons), continuously stirring to enable the mixture to be uniformly swelled, and centrifuging to remove bubbles to obtain the viscous liquid.
2) Preparation of soluble cosmetic microneedles:
the same as in example 1.
3) Preparation of hydrogel adhesive film:
the same as in example 1.
Example 3
A preparation method of a soluble cosmetic microneedle patch composition for removing dark circles and pouches comprises the following steps:
1) preparation of viscous liquid:
adding 0.3% of centella asiatica extract, 0.5% of aesculus hippocastanum extract, 0.1% of heparin sodium and 0.3% of caffeine into the balance of water, stirring and dissolving, adding 10% of glycerol, 2% of sodium hyaluronate (with the molecular weight of 5000 daltons) and 8% of sodium hyaluronate (with the molecular weight of 60 ten thousand daltons), continuously stirring to enable the mixture to be uniformly swelled, and centrifuging to remove bubbles to obtain the viscous liquid.
2) Preparation of soluble cosmetic microneedles:
the same as in example 1.
3) Preparation of hydrogel adhesive film:
the same as in example 1.
Blank example 1
A preparation method of a soluble cosmetic microneedle patch composition comprises the following steps:
1) preparation of viscous liquid:
adding 10% glycerol, 2% sodium hyaluronate (molecular weight of 5000 daltons) and 8% sodium hyaluronate (molecular weight of 60 ten thousand daltons) into the balance of water, stirring to make it swell uniformly, centrifuging to remove bubbles, and obtaining the viscous liquid.
2) Preparation of soluble cosmetic microneedles:
the same as in example 1.
3) Preparation of hydrogel adhesive film:
the same as in example 1.
Test example for Effect verification
First, black eye removing efficacy analysis experiment
The soluble cosmetic microneedle patch compositions obtained in examples 1 to 3 and blank example 1 were subjected to a dark eye circle removal effect test.
1. The tester: 40 healthy women (25-35 years old) divided into 4 groups of 10 persons each; each group used the same formulation.
2. Test area: the lower eyelid and the external canthus (left eye blank example 1 sample, right eye example sample).
3. Use of: it is administered once daily for 40min for 6 weeks.
4. Testing an instrument: DelfinSkinColorCatch (finland).
5. The effect indexes are as follows: the change in color brightness (Δ L), ITA degree, and the L value (brightness) and ITA degree (color individual type angle) were measured and mainly used as indices.
Equation (1): Δ L ═ L (after 1 month of test on control or example products) -L (before the start of test) ] - [ L ═ L (after 1 month of test on blank product) -L (before the start of test).
(2): ITA degree (representing the overall change of chromaticity, the larger the ITA degree value is, the lighter the skin color is.)
TABLE 1 skin color Classification at different ITA ° ranges
The test effects are shown in table 2 below.
TABLE 2 test results
As can be seen from table 2, the soluble cosmetic microneedle patch composition for removing black eye circles and under-eye pouches obtained in examples 1 to 3 of the present invention can effectively lighten the black eye circles and brighten the skin color of the eye, while the soluble cosmetic microneedle patch composition for removing black eye circles and under-eye pouches obtained in blank example 1 cannot lighten the black eye circles. The black eye and pouch removing composition has the effect of removing black eyes.
Second, synergistic Experimental example
Comparative examples 1 to 14
The formulation of a viscous liquid component of a soluble cosmetic microneedle patch composition is shown in tables 3-4 below:
TABLE 3 viscous liquid composition ratio (% by weight)
TABLE 4 ingredient ratio (wt%)
The preparation process is the same as that described in example 1.
The soluble cosmetic microneedle patch compositions obtained in example 1, comparative examples 1 to 14, and blank example 1 were subjected to a pouch removal effect test.
160 human subjects (25-45 years old) were administered to each group of 10 human subjects 1 time per eye day for 40min for 1 month.
Primos was used for facial image acquisition and pouch analysis.
The test effects are shown in table 5 below.
TABLE 5 test results
As can be seen from the test data in table 5, the wrinkle-removing effect is ranked as example 1> comparative example 11, 12, 13, 14> comparative example 5, 6, 7, 8, 9, 10> comparative example 1, 2, 3, 4, and it is demonstrated that the black eye and pouch removing composition has better pouch removing effect than the combination of one, two or three components alone through the synergistic effect between the components.
Third, human body trial evaluation experiment
The experimental method comprises the following steps: the black eye-removing and pouch-dissolving cosmetic microneedle patch composition prepared in examples 1, 2 and 3 and blank example 1 was selected as an experimental sample, and the experimental evaluation was performed on the sample of the volunteer.
80 volunteers 25-45 years old were selected and randomized into 4 groups of 20 individuals each. Samples of soluble cosmetic microneedle patch compositions prepared in examples 1, 2, 3 and blank 1 were used in 4 groups of volunteers, respectively. The using method comprises the following steps: after cleaning face, the face lotion is used once a day, each time is 40min, the face lotion is continuously used for 4 weeks, and sensory evaluation is carried out according to the improvement condition of black eye and pouch. The results obtained for each group are shown in table 6:
TABLE 6 test results
| Evaluation results | Effective in removing black eye | Has the effect of removing eye bags |
| Example 1 | 85％ | 80％ |
| Example 2 | 75％ | 75％ |
| Example 3 | 70％ | 60％ |
| Blank example 1 | 5％ | 5％ |
As can be seen from table 6, the soluble cosmetic microneedle patch composition for removing black eye circles and under-eye pouches obtained in examples 1 to 3 of the present invention can effectively remove black eye circles and under-eye pouches, and the effect is superior to that of the soluble cosmetic microneedle patch composition for removing black eye circles and under-eye pouches of the blank example 1.
In conclusion, the composition for removing the black eye circles and the under-eye puffiness is specially designed for weak skin around eyes, so that the microcirculation of the skin around the eyes is promoted, the red blood streak is improved, the penetration of capillary vessels is reduced, and the activity of skin basal layer cells can be enhanced. The composition with the black eye and pouch removing effects is wrapped by the soluble cosmetic microneedle, so that the composition can be better absorbed through skin penetration to play a better nursing effect, is beneficial to more slow release of the effect composition, has small irritation, has excellent effect on skin around eyes and is easy to use.
The microneedle patch prepared by the invention has the effects of relieving eye fatigue, removing dark circles, fading pouches and tightening skin around eyes. The hydrogel patch is matched with the soluble microneedle for use, can release the moisture of the hydrogel patch in the absence of water, has self-adhesion and low sensitization, can cover the soluble cosmetic microneedle on the skin to be difficult to fall off, and ensures that the wrinkle-removing and anti-aging effects of the microneedle are stably exerted.
The above description is only a preferred embodiment of the present invention, and is not intended to limit the present invention in any way, and other variations and modifications may be made without departing from the spirit of the invention as set forth in the claims.
Claims (10)
1. A cosmetic micro-needle film composition capable of removing dark circles and pouches is characterized in that: comprises a base, a needle body positioned on the base and a hydrogel adhesive film for relieving and fixing the needle body;
the needle body is internally embedded with a composition for removing black eye circles and under-eye bags, and the composition for removing black eye circles and under-eye bags comprises the following components in percentage by total weight of the micro-needles:
0.1-5% of centella asiatica extract, 0.1-5% of aesculus hippocastanum extract, 0.1-2% of heparin sodium and 0.1-3% of caffeine.
2. The dark-eyed, under-eye soluble cosmetic microneedle patch composition according to claim 1, wherein: the black eye and pouch removing composition comprises the following components in percentage by weight based on the total weight of the micro-needle:
0.2-2% of centella asiatica extract, 0.2-2% of aesculus hippocastanum extract, 0.1-0.5% of heparin sodium and 0.1-1% of caffeine.
3. The dark-eyed, under-eye soluble cosmetic microneedle patch composition according to claim 1, wherein:
the composition for removing black eye circles and under-eye bags further comprises the following components in percentage by weight:
5-15% of glycerin, 1-3% of low molecular weight sodium hyaluronate and 6-10% of high molecular weight sodium hyaluronate.
4. The dark-eyed, under-eye soluble cosmetic microneedle patch composition according to claim 1, wherein:
the soluble cosmetic microneedle is conical, the main component is hyaluronic acid, the length of the needle head is 150-.
5. The dark-eyed, under-eye soluble cosmetic microneedle patch composition according to claim 1, wherein:
the hydrogel adhesive film has 4 layers, and the components are 15-25; the hydrogel adhesive film consists of non-woven fabric, hydrogel, an active component layer and a protective film from top to bottom;
the non-woven fabric is non-woven fabric and is formed by solidifying high polymer slices, short fibers or filaments;
the hydrogel comprises the following specific components in percentage by weight of the hydrogel adhesive film: 5-15% of glycerol, 1-2% of sodium polyacrylate, 1-3% of aluminum dihydroxyglycinate, 0.5-2% of cellulose gum, 1-5% of tartaric acid, 5-15% of butanediol and 50-80% of water;
according to the total weight of the hydrogel adhesive film, the active component layer comprises the following specific components:
0.1-2% of centella asiatica extract, 0.2-3% of polygonum cuspidatum root extract, 0.2-3% of scutellaria baicalensis root extract, 0.1-2% of tea leaf extract, 0.2-3% of glycyrrhiza glabra root extract, 0.3-1% of chamomile flower extract and 0.1-2% of rosemary leaf extract;
the protective film is a white plastic film.
6. The method for preparing a dark-eyed, pouch-removing soluble cosmetic microneedle patch composition according to any one of claims 1 to 5, characterized in that: the method comprises the following steps:
1) preparation of viscous liquid:
adding the composition for removing dark circles and pouches into the balance of water, stirring and dissolving, adding 5-15% of glycerol, 1-3% of low molecular weight sodium hyaluronate and 6-10% of high molecular weight sodium hyaluronate, continuing stirring to enable the mixture to be uniformly swelled, and centrifuging to remove bubbles to obtain viscous liquid;
2) preparation of soluble cosmetic microneedles:
injecting the viscous liquid into a microneedle mould, drying and demoulding to obtain a soluble cosmetic microneedle;
3) preparation of hydrogel adhesive film:
uniformly mixing 1-2% of sodium polyacrylate and 1-3% of dihydroxy aluminum glycinate, adding 5-15% of glycerol and 5-15% of butanediol, and fully stirring to obtain a phase A solution;
adding 0.5-2% cellulose gum into water, stirring, adding 1-5% tartaric acid, adding active component layer, stirring to dissolve completely to obtain B phase solution;
and adding the B phase solution into the A phase solution, stirring in vacuum to obtain hydrogel paste, and finally coating the hydrogel paste on a coating machine together with a non-woven fabric and a protective film to obtain the hydrogel adhesive film.
7. The method for preparing the black eye-circle-removing and pouch-dissolving cosmetic microneedle patch composition according to claim 6, wherein: in the step 1), the molecular weight of the low molecular weight sodium hyaluronate is 2000-10000 Dalton; the molecular weight of the high molecular weight sodium hyaluronate is 40-100 ten thousand daltons;
the mass ratio of the high molecular weight sodium hyaluronate to the low molecular weight sodium hyaluronate is 1: 3.5-5.5.
8. The method for preparing the black eye-circle-removing and pouch-dissolving cosmetic microneedle patch composition according to claim 6, wherein: in the step 2), the microneedle mould is arc-shaped, and two ends of the microneedle mould are arc-shaped.
9. The method for preparing the black eye-circle-removing and pouch-dissolving cosmetic microneedle patch composition according to claim 6, wherein: in the step 2), the drying temperature is room temperature, the humidity is 15-25%, and the drying time is 12-24 h.
10. The method for preparing the black eye-circle-removing and pouch-dissolving cosmetic microneedle patch composition according to claim 6, wherein: in the step 3), the stirring speed of the vacuum stirring is 50-120r/min, and the stirring time is 5-15 min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111271937.9A CN113876656A (en) | 2021-10-29 | 2021-10-29 | Black eye and pouch removing soluble beautifying microneedle patch composition and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111271937.9A CN113876656A (en) | 2021-10-29 | 2021-10-29 | Black eye and pouch removing soluble beautifying microneedle patch composition and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113876656A true CN113876656A (en) | 2022-01-04 |
Family
ID=79015011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111271937.9A Pending CN113876656A (en) | 2021-10-29 | 2021-10-29 | Black eye and pouch removing soluble beautifying microneedle patch composition and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113876656A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115531266A (en) * | 2022-09-30 | 2022-12-30 | 泉后(广州)生物科技研究院有限公司 | Composition for removing eye bags and application thereof |
Citations (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20160145476A (en) * | 2015-06-10 | 2016-12-20 | 주식회사 엘지생활건강 | Soluble Microneedle patch for Centella asiatica delivery |
| CN106420590A (en) * | 2015-08-07 | 2017-02-22 | 玫琳凯有限公司 | Topical cosmetic compositions |
| CN106619322A (en) * | 2017-02-11 | 2017-05-10 | 佛山市芊茹化妆品有限公司 | Eye masks with function of removing eye bags |
| JP2017145226A (en) * | 2016-02-19 | 2017-08-24 | 日本写真印刷株式会社 | Microneedle sheet |
| CN108261368A (en) * | 2018-02-09 | 2018-07-10 | 广州重生化妆品实业有限公司 | A kind of compound goes pouch gel and its preparation process |
| CN108498941A (en) * | 2018-04-25 | 2018-09-07 | 武汉德丽福生物科技有限公司 | Micropin Beauty sticking piece with and preparation method thereof |
| CN108852938A (en) * | 2018-08-16 | 2018-11-23 | 艾因特丽（苏州）生物科技有限公司 | A kind of compound formulation for the eye pouch that has effects that dispel |
| CN109453089A (en) * | 2018-12-29 | 2019-03-12 | 吕飞 | Exquisite anti-age corrective eye treatment cream and preparation method thereof |
| CN109602655A (en) * | 2018-12-25 | 2019-04-12 | 广州葆妍生物科技有限公司 | It is a kind of with it is crease-resistant, remove black eye, the composition for going eye pouch effect and its preparation method and application |
| CN110141560A (en) * | 2019-06-28 | 2019-08-20 | 广州市白云区大荣精细化工有限公司 | A kind of Medical cold application and preparation method thereof |
| CN110947088A (en) * | 2019-12-06 | 2020-04-03 | 广州新济薇娜生物科技有限公司 | Eye-protecting combined patch and preparation method thereof |
| CN111544759A (en) * | 2020-04-26 | 2020-08-18 | 优微（珠海）生物科技有限公司 | Microneedle patch for removing black eye circles and preparation method thereof |
| CN112190507A (en) * | 2020-10-28 | 2021-01-08 | 广州品赫化妆品有限公司 | Composition containing poria cocos extract for removing dark circles and resisting wrinkles as well as preparation method and application of composition |
| CN112206200A (en) * | 2020-09-18 | 2021-01-12 | 珠海海狮龙生物科技有限公司 | Full-effect crystal eye mask and preparation method thereof |
| CN112312889A (en) * | 2018-04-20 | 2021-02-02 | Lvmh研究公司 | Cosmetic composition comprising aqueous extract of rose fruit |
| CN112933034A (en) * | 2021-03-04 | 2021-06-11 | 广州市珍榜日用化工有限公司 | Eye repair and nursing composition capable of removing dark circles, essence emulsion and preparation method |
-
2021
- 2021-10-29 CN CN202111271937.9A patent/CN113876656A/en active Pending
Patent Citations (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20160145476A (en) * | 2015-06-10 | 2016-12-20 | 주식회사 엘지생활건강 | Soluble Microneedle patch for Centella asiatica delivery |
| CN106420590A (en) * | 2015-08-07 | 2017-02-22 | 玫琳凯有限公司 | Topical cosmetic compositions |
| JP2017145226A (en) * | 2016-02-19 | 2017-08-24 | 日本写真印刷株式会社 | Microneedle sheet |
| CN106619322A (en) * | 2017-02-11 | 2017-05-10 | 佛山市芊茹化妆品有限公司 | Eye masks with function of removing eye bags |
| CN108261368A (en) * | 2018-02-09 | 2018-07-10 | 广州重生化妆品实业有限公司 | A kind of compound goes pouch gel and its preparation process |
| CN112312889A (en) * | 2018-04-20 | 2021-02-02 | Lvmh研究公司 | Cosmetic composition comprising aqueous extract of rose fruit |
| CN108498941A (en) * | 2018-04-25 | 2018-09-07 | 武汉德丽福生物科技有限公司 | Micropin Beauty sticking piece with and preparation method thereof |
| CN108852938A (en) * | 2018-08-16 | 2018-11-23 | 艾因特丽（苏州）生物科技有限公司 | A kind of compound formulation for the eye pouch that has effects that dispel |
| CN109602655A (en) * | 2018-12-25 | 2019-04-12 | 广州葆妍生物科技有限公司 | It is a kind of with it is crease-resistant, remove black eye, the composition for going eye pouch effect and its preparation method and application |
| CN109453089A (en) * | 2018-12-29 | 2019-03-12 | 吕飞 | Exquisite anti-age corrective eye treatment cream and preparation method thereof |
| CN110141560A (en) * | 2019-06-28 | 2019-08-20 | 广州市白云区大荣精细化工有限公司 | A kind of Medical cold application and preparation method thereof |
| CN110947088A (en) * | 2019-12-06 | 2020-04-03 | 广州新济薇娜生物科技有限公司 | Eye-protecting combined patch and preparation method thereof |
| CN111544759A (en) * | 2020-04-26 | 2020-08-18 | 优微（珠海）生物科技有限公司 | Microneedle patch for removing black eye circles and preparation method thereof |
| CN112206200A (en) * | 2020-09-18 | 2021-01-12 | 珠海海狮龙生物科技有限公司 | Full-effect crystal eye mask and preparation method thereof |
| CN112190507A (en) * | 2020-10-28 | 2021-01-08 | 广州品赫化妆品有限公司 | Composition containing poria cocos extract for removing dark circles and resisting wrinkles as well as preparation method and application of composition |
| CN112933034A (en) * | 2021-03-04 | 2021-06-11 | 广州市珍榜日用化工有限公司 | Eye repair and nursing composition capable of removing dark circles, essence emulsion and preparation method |
Non-Patent Citations (1)
| Title |
|---|
| 王聪敏等, 中国医药科技出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115531266A (en) * | 2022-09-30 | 2022-12-30 | 泉后(广州)生物科技研究院有限公司 | Composition for removing eye bags and application thereof |
| CN115531266B (en) * | 2022-09-30 | 2024-03-12 | 泉后(广州)生物科技研究院有限公司 | Composition for removing pouch and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102641228B (en) | Rhodiola crenulata eye cream with whitening and anti-wrinkle effects | |
| CN103932970A (en) | Chinese herbal medicine freckle-removal compound cosmetic and preparation method thereof | |
| CN104784507A (en) | Traditional Chinese medicine composition with multiple cosmetic effects and application | |
| CN104800537B (en) | A kind of hair growth and the Chinese medicine composition and preparation method thereof with black hair function | |
| CN109044941B (en) | Skin firming, nourishing and moisturizing composition and preparation method and application thereof | |
| CN102988264A (en) | Ginkgo leaf freckle removing whitening cream and preparation method thereof | |
| CN105496917A (en) | Herba centellae anti-wrinkling face cream and preparation method thereof | |
| CA2823423A1 (en) | Moisturizing chinese herbal medicine composition, preparation method and use thereof | |
| CN105267477A (en) | Danshen leaf health tea capable of removing liver-fire for improving eyesight and preparation method of Danshen leaf health tea | |
| CN105342908A (en) | Centella asiatica beauty and anti-wrinkle traditional Chinese medicinal ointment for relieving wrinkles and preparation method of traditional Chinese medicinal ointment | |
| CN112933034A (en) | Eye repair and nursing composition capable of removing dark circles, essence emulsion and preparation method | |
| CN108888563A (en) | A kind of water profit thirst quenching hydra-balance mask and preparation method thereof | |
| CN106309260B (en) | A kind of Radix Notoginseng is preserved youthful looks facial mask | |
| CN105616318A (en) | Anti-wrinkle and skin-firming herba centellae traditional Chinese medicine facial mask and preparation method therefor | |
| CN110151866A (en) | A kind of nutritional supplement for improving eyesight and preparation method thereof and purposes | |
| KR101795709B1 (en) | Visage improvement patch and manufacturing method of same | |
| CN108309873B (en) | Activation-balanced conditioning essence | |
| CN113876656A (en) | Black eye and pouch removing soluble beautifying microneedle patch composition and preparation method thereof | |
| CN109663070A (en) | Beauty treatment and eliminating spot liquid and preparation method thereof | |
| CN109010220B (en) | Cosmetic composition and preparation method thereof | |
| CN103690854A (en) | External-use traditional Chinese medicine composition with hair growing and hair loss preventing effects and preparation method for external-use traditional Chinese medicine composition | |
| CN105748901A (en) | Formula and preparation method of health-care beverage | |
| CN109568230A (en) | A kind of Chinese medicine cosmetic of the anti-aging of moisturizing whitening | |
| CN104888158A (en) | Folium apocyni veneti oral liquid for enhancing immunity and preparation method thereof | |
| CN104473153A (en) | Beautifying mulberry oral liquid and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20220104 |
|
| WD01 | Invention patent application deemed withdrawn after publication |